Article Underestimated Risks in Bladder Cancer Drug Development Challenges that derail oncology programs and how to anticipate them earlier Bladder cancer programs don’t Read Now Case Study Tailored Approach Supports Bladder Cancer Breakthrough Since 2020, Catalyst Oncology has supported an emerging biotech’s oncology program. Focused on developing the Read Now Blog Transforming Cancer Treatment with the Power of the Immune System Cancer rates continue to rise globally, creating an urgent need for more effective and innovative Read Now Blog ASH 2025 Highlights Bispecifics, CAR-T cell therapy and the future of hematologic oncology The American Society of Hematology Read Now Case Study Accelerating a Global, FIH ADC Therapy Trial for Lung Cancer An innovative biotech was developing a next-generation antibody-drug conjugate (ADC) for the treatment of non-small Read Now Article Advancing Breast Cancer Clinical Trials Strategic solutions for complex challenges Breast cancer is the most common cancer in women worldwide, Read Now Article Shaping the Future of Hematologic Oncology   Clinical Innovation and Trial Execution Strategies  Blood cancers—including leukemia, lymphoma, and multiple myeloma—are among the Read Now Webinar Best Practices to Ensure a Smooth CRO Handoff and Data Continuity Transitioning biometrics and other critical services from one contract research organization (CRO) or functional service Read Now Blog Transform Relationship Management into a Strategic Advantage  Leveraging Our Core Culture In the dynamic world of clinical trials and data management, success Read Now Press Release Catalyst Welcomes New Quality Management Executive Catalyst Clinical Research is excited to welcome Melissa Vozza, Vice President of Quality Management. With Read Now